Back to Market返回行情

PHR Phreesia, Inc.

USHealthcare
$10.74-0.74%OpenMarket Cap: $663.9M

As of 2026-07-10 11:56

Why PHR matters now

Phreesia, Inc. (PHR) is a US stock in Healthcare. The latest InvestLog snapshot shows $10.74 with -0.74% on the session and $663.9M in market capitalization; recent performance reads 1-month +2.29% and YTD -44.56%.

The latest financial table shown here is Q1 2027, with revenue of $130.9M, net income of $3.0M, and EPS of $0.05. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield 12.7%.

The latest indexable market news headline is "Deadline Soon: Phreesia Inc. (PHR) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit" from Business Wire.

Additional event context on this page matters because analyst consensus is Hold with a median target of $12.00; recent insider activity includes Hui Yvonne filing F-InKind; recent congressional disclosure data includes Josh Gottheimer Sale. These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

PEG

P/B

1.59

P/S

1.17

EV/EBITDA

14.09

DCF Value

$50.52

FCF Yield

12.7%

Div Yield

0.0%

Margins & Returns

Gross Margin

65.8%

Operating Margin

0.7%

Net Margin

1.9%

ROE

2.8%

ROA

1.4%

ROIC

-6.2%

Financials

PeriodRevenueNet IncomeEPS
Q1 2027$130.9M$3.0M$0.05
Q4 2026$127.1M$1.3M$0.02
FY 2026$480.6M$2.3M$0.04
Q3 2026$120.3M$4.3M$0.07

Analyst Ratings

Consensus

Hold

Target (Consensus)

$13.57

Target (Median)

$12.00

Target Range

$9.00 - $22.00

Strong Buy: 3Buy: 9Hold: 8Sell: 0Strong Sell: 0
Truist SecuritiesHold
2026-05-29
DA DavidsonBuy
2026-05-28
CitigroupNeutral
2026-05-28
Canaccord GenuityBuy
2026-05-28
Wells FargoEqual Weight
2026-05-20

Trading Activity

Insider Trades

Hui Yvonneofficer: Principal Accounting Officer
Sell2026-05-20
Hui Yvonneofficer: Principal Accounting Officer
Sell2026-05-20
Munson Gilliandirector
Sell2026-05-04
Goldstein Lainiedirector
Sell2026-05-04
CAHILL EDWARD Ldirector
Sell2026-05-04

Congress Trades

Josh GottheimerSell
2026-04-09

Company Info

Sector

Healthcare

Industry

Medical - Healthcare Information Services

Country

US

Exchange

Beta

0.88

Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.